Janelle M. Wright

Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2′-deoxyadenosine

P. Upcroft, J. Upcroft, Z. Kazimierczuk, 2010, Parasitology Research.

Efficacy of antigiardial drugs

P. Upcroft, J. Upcroft, J. Wright, 2003, Expert opinion on drug safety.

Exploring the Fasciola hepatica tegument proteome.

N. Young, R. Gasser, P. Ashton, 2011, International journal for parasitology.

5-Nitroimidazole Drugs Effective against Metronidazole-Resistant Trichomonas vaginalis and Giardia duodenalis

P. Upcroft, J. Upcroft, K. Benakli, 2006, Antimicrobial Agents and Chemotherapy.

Hydrogenosomes of Laboratory‐Induced Metronidazole‐Resistant Trichomonas vaginalis Lines are Downsized While Those from Clinically Metronidazole‐Resistant Isolates Are Not

P. Upcroft, J. Upcroft, R. Webb, 2010, The Journal of eukaryotic microbiology.

The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.

J. McCarthy, P. Upcroft, K. Andrews, 2007, International journal of antimicrobial agents.